OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

COPART INC (CPRT) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

CPRT · COPART INC

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-10-27 · 11 filings · fetched 2026-10-27T16:23:50Z

Recent reported activity

0purchase rows on this page
3sale rows on this page
23matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-15Filed 2026-10-19Morefield Diane MDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.64 to $27.70, inclusive. The reporting person undertakes to provide to Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

References: F1

S Sale (market/private)Common Stock · Non-derivative20,000D27.66DirectForm 4 ↗0001193125-26-425293
2026-10-09Filed 2026-10-21JOHNSON WILLIS JDirector · Officer · Chairman of the Board
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The shares were transferred by the Willis J. Johnson and Reba Johnson Revocable Trust to a separate trust for which the reporting person's wife serves as trustee.

F2 The shares were transferred from the Willis J. Johnson and Reba Johnson Revocable Trust to the 2026 Willis Johnson Qualified Annuity Trust, for which the reporting person serves as trustee.

References: F2

J Other reported codeCommon Stock · Non-derivative3,090,000A0IndirectThe 2026 Willis J. Johnson Qualified Annuity TrustForm 4 ↗0001193125-26-428030
2026-10-09Filed 2026-10-21JOHNSON WILLIS JDirector · Officer · Chairman of the Board
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The shares were transferred by the Willis J. Johnson and Reba Johnson Revocable Trust to a separate trust for which the reporting person's wife serves as trustee.

F2 The shares were transferred from the Willis J. Johnson and Reba Johnson Revocable Trust to the 2026 Willis Johnson Qualified Annuity Trust, for which the reporting person serves as trustee.

References: F2

J Other reported codeCommon Stock · Non-derivative3,090,000D0IndirectWillis J. Johnson and Reba Johnson Revocable TrustForm 4 ↗0001193125-26-428030
2026-10-09Filed 2026-10-21JOHNSON WILLIS JDirector · Officer · Chairman of the Board
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The shares were transferred by the Willis J. Johnson and Reba Johnson Revocable Trust to a separate trust for which the reporting person's wife serves as trustee.

F2 The shares were transferred from the Willis J. Johnson and Reba Johnson Revocable Trust to the 2026 Willis Johnson Qualified Annuity Trust, for which the reporting person serves as trustee.

References: F1

J Other reported codeCommon Stock · Non-derivative3,090,000D0IndirectWillis J. Johnson and Reba Johnson Revocable Trust ReERForm 4 ↗0001193125-26-428030
2026-08-16Filed 2026-08-18STEARNS LEAH COfficer · Chief Financial Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of Copart, Inc. common stock.

F2 Twenty percent of the Restricted Stock Units (RSUs) vest on the first anniversary of the grant date (August 16, 2027), and the balance vests cumulatively at a rate of 1/20 each three month quarter thereafter, such that 100% of the RSUs will vest on the fifth anniversary of the grant date.

F3 100% of the stock options are subject to time -based vesting, with 20% of the stock options vesting on the first anniversary of the grant date, and the balance vesting at a rate of 1/60 per month thereafter, such that 100% of the stock options will vest and become exerciseable on the fifth anniversary of the grant date. In addition to the time-based vesting, 114,400 of the stock options are subject to an additional performance-based vesting condition and will not be exerciseable unless and until the trading price of the Copart, Inc. Common Stock in trading on the Nasdaq Global Select Market is an amount greater than or equal to $39.51 (125% of the per share exercise price) both (1) at the moment of any exercise, and (2) at the closing price for each of the twenty consecutive trading days preceding the date of any exercise.

References: F3

A Award / grantStock Options · Derivative200,000A0DirectForm 4 ↗0001193125-26-355725
2026-08-16Filed 2026-08-18STEARNS LEAH COfficer · Chief Financial Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of Copart, Inc. common stock.

F2 Twenty percent of the Restricted Stock Units (RSUs) vest on the first anniversary of the grant date (August 16, 2027), and the balance vests cumulatively at a rate of 1/20 each three month quarter thereafter, such that 100% of the RSUs will vest on the fifth anniversary of the grant date.

F3 100% of the stock options are subject to time -based vesting, with 20% of the stock options vesting on the first anniversary of the grant date, and the balance vesting at a rate of 1/60 per month thereafter, such that 100% of the stock options will vest and become exerciseable on the fifth anniversary of the grant date. In addition to the time-based vesting, 114,400 of the stock options are subject to an additional performance-based vesting condition and will not be exerciseable unless and until the trading price of the Copart, Inc. Common Stock in trading on the Nasdaq Global Select Market is an amount greater than or equal to $39.51 (125% of the per share exercise price) both (1) at the moment of any exercise, and (2) at the closing price for each of the twenty consecutive trading days preceding the date of any exercise.

References: F1, F2

A Award / grantRestricted Stock Units · Derivative12,654A0DirectForm 4 ↗0001193125-26-355725
2026-08-16Filed 2026-08-18Pocock JaneOfficer · President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of Copart, Inc. common stock.

F2 Twenty percent of the Restricted Stock Units (RSUs) vest on the first anniversary of the grant date (August 16, 2027), and the balance vests cumulatively at a rate of 1/20 each three month quarter thereafter, such that 100% of the RSUs will vest on the fifth anniversary of the grant date.

F3 100% of the stock options are subject to time -based vesting, with 20% of the stock options vesting on the first anniversary of the grant date, and the balance vesting at a rate of 1/60 per month thereafter, such that 100% of the stock options will vest and become exerciseable on the fifth anniversary of the grant date. In addition to the time-based vesting, 279,000 of the stock options are subject to an additional performance-based vesting condition and will not be exerciseable unless and until the trading price of the Copart, Inc. Common Stock in trading on the Nasdaq Global Select Market is an amount greater than or equal to $39.51 (125% of the per share exercise price) both (1) at the moment of any exercise, and (2) at the closing price for each of the twenty consecutive trading days preceding the date of any exercise.

References: F3

A Award / grantStock Options · Derivative500,000A0DirectForm 4 ↗0001193125-26-355690
2026-08-16Filed 2026-08-18Pocock JaneOfficer · President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of Copart, Inc. common stock.

F2 Twenty percent of the Restricted Stock Units (RSUs) vest on the first anniversary of the grant date (August 16, 2027), and the balance vests cumulatively at a rate of 1/20 each three month quarter thereafter, such that 100% of the RSUs will vest on the fifth anniversary of the grant date.

F3 100% of the stock options are subject to time -based vesting, with 20% of the stock options vesting on the first anniversary of the grant date, and the balance vesting at a rate of 1/60 per month thereafter, such that 100% of the stock options will vest and become exerciseable on the fifth anniversary of the grant date. In addition to the time-based vesting, 279,000 of the stock options are subject to an additional performance-based vesting condition and will not be exerciseable unless and until the trading price of the Copart, Inc. Common Stock in trading on the Nasdaq Global Select Market is an amount greater than or equal to $39.51 (125% of the per share exercise price) both (1) at the moment of any exercise, and (2) at the closing price for each of the twenty consecutive trading days preceding the date of any exercise.

References: F1, F2

A Award / grantRestricted Stock Units · Derivative25,308A0DirectForm 4 ↗0001193125-26-355690
2026-08-13Filed 2026-08-17Berger David JoelDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Options vest on a monthly basis over the 12 months succeeding the grant date.

F2 2007 Equity Incentive Plan.

References: F1, F2

A Award / grantStock Option · Derivative24,341A0DirectForm 4 ↗0001193125-26-354472
2026-07-28Filed 2026-07-30Liaw JeffreyOfficer · Chief Executive Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.

F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

References: F3

M Exercise / conversionStock Option · Derivative43,166D0DirectForm 4 ↗0001193125-26-326503
2026-07-28Filed 2026-07-30Liaw JeffreyOfficer · Chief Executive Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.

F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

References: F2

M Exercise / conversionStock Option · Derivative3,591D0DirectForm 4 ↗0001193125-26-326503
2026-07-28Filed 2026-07-30Liaw JeffreyOfficer · Chief Executive Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.

F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

References: F1

S Sale (market/private)Common Stock · Non-derivative27,745D30.49DirectForm 4 ↗0001193125-26-326503
2026-07-28Filed 2026-07-30Liaw JeffreyOfficer · Chief Executive Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.

F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

References:

M Exercise / conversionCommon Stock · Non-derivative43,166A8.7DirectForm 4 ↗0001193125-26-326503
2026-07-28Filed 2026-07-30Liaw JeffreyOfficer · Chief Executive Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.

F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

References:

M Exercise / conversionCommon Stock · Non-derivative3,591A6.78DirectForm 4 ↗0001193125-26-326503
2026-07-15Filed 2026-07-17Liaw JeffreyOfficer · Chief Executive Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

References: F2

M Exercise / conversionStock Option · Derivative812D0DirectForm 4 ↗0001193125-26-307951
2026-07-15Filed 2026-07-17Liaw JeffreyOfficer · Chief Executive Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

References: F1

M Exercise / conversionStock Option · Derivative1,277D0DirectForm 4 ↗0001193125-26-307951
2026-07-15Filed 2026-07-17Liaw JeffreyOfficer · Chief Executive Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

References:

M Exercise / conversionCommon Stock · Non-derivative812A8.7DirectForm 4 ↗0001193125-26-307951
2026-07-15Filed 2026-07-17Liaw JeffreyOfficer · Chief Executive Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

References:

M Exercise / conversionCommon Stock · Non-derivative1,277A6.78DirectForm 4 ↗0001193125-26-307951
2026-07-13Filed 2026-07-15Englander Daniel JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.66, inclusive. The reporting person undertakes to provide to Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 Includes 275,352 shares held by Ursula Capital Partners, for which Mr. Englander serves as the sole general partner.

F3 The reporting person is general partner of Ursula Capital Partners. On July 13, 2026, the reporting person caused Ursula Capital Partners to distribute 40,000 shares of Copart, Inc. common stock to its limited partners (excluding the reporting person).

F4 Includes 235,352 shares owned by Ursula Capital Partners, for which Mr. Englander serves as the sole general partner.

References: F3, F4

J Other reported codeCommon Stock · Non-derivative40,000D0IndirectUrsual Capital PartnersForm 4 ↗0001193125-26-304271
2026-07-13Filed 2026-07-15Englander Daniel JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.66, inclusive. The reporting person undertakes to provide to Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 Includes 275,352 shares held by Ursula Capital Partners, for which Mr. Englander serves as the sole general partner.

F3 The reporting person is general partner of Ursula Capital Partners. On July 13, 2026, the reporting person caused Ursula Capital Partners to distribute 40,000 shares of Copart, Inc. common stock to its limited partners (excluding the reporting person).

F4 Includes 235,352 shares owned by Ursula Capital Partners, for which Mr. Englander serves as the sole general partner.

References: F1, F2

S Sale (market/private)Common Stock · Non-derivative80,000D27.55IndirectUrsula Capital PartnersForm 4 ↗0001193125-26-304271
2026-07-08Filed 2026-07-10Morefield Diane MDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 2007 Equity Incentive Plan

F2 Options vested on a monthly basis over the 12 months succeeding the grant date.

References: F1, F2

M Exercise / conversionStock Option · Derivative50,000D0DirectForm 4 ↗0001193125-26-300603
2026-07-08Filed 2026-07-10Morefield Diane MDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 2007 Equity Incentive Plan

F2 Options vested on a monthly basis over the 12 months succeeding the grant date.

References:

M Exercise / conversionCommon Stock · Non-derivative50,000A19.775DirectForm 4 ↗0001193125-26-300603
2025-12-10Filed 2026-10-21JOHNSON WILLIS JDirector · Officer · Chairman of the Board
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The shares were transferred by the Willis J. Johnson and Reba Johnson Revocable Trust to a separate trust for which the reporting person's wife serves as trustee.

F2 The shares were transferred from the Willis J. Johnson and Reba Johnson Revocable Trust to the 2026 Willis Johnson Qualified Annuity Trust, for which the reporting person serves as trustee.

References:

G GiftCommon Stock · Non-derivative129,200D0IndirectWillis and Reba's FoundationForm 4 ↗0001193125-26-428030

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.